Development of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies
Author(s) -
George S. Laszlo,
Johnnie J. Orozco,
Allie R. Kehret,
Margaret C. Lunn-Halbert,
Jenny Huo,
Donald K. Hamlin,
D. Scott Wilbur,
Shan L. Dexter,
Melissa L. Comstock,
Shyril O’Steen,
Brenda M. Sandmaier,
Damian J. Green,
Roland B. Walter
Publication year - 2022
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/s41375-022-01580-7
Subject(s) - radioimmunotherapy , interleukin 3 receptor , leukemia , cancer research , monoclonal antibody , medicine , stem cell , immunology , biology , antibody , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom